BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD AND Treatment
10817 results:

  • 1. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
    BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. EPAS1, a hypoxia- and ferroptosis-related gene, promotes malignant behaviour of cervical cancer by ceRNA and super-enhancer.
    Lu X; Zhang W; Zhang J; Ren D; Zhao P; Ying Y
    J Cell Mol Med; 2024 May; 28(9):e18361. PubMed ID: 38722283
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
    Zeng F; Guo P; Xia M; He M
    J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
    J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Mooses K; Šavrova A; Pajusalu M; Oja M; Tamm S; Haug M; Padrik L; Laanpere M; Uusküla A; Kolde R
    Prev Med; 2024 Jun; 183():107982. PubMed ID: 38701952
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort study.
    Lüchtenborg M; Huynh J; Armes J; Plugge E; Hunter RM; Visser R; Taylor RM; Davies EA
    Lancet Oncol; 2024 May; 25(5):553-562. PubMed ID: 38697154
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [cervical CUP Syndrome: Diagnosis and Therapy].
    Lammert A; Abo-Madyan Y; Huber L; Ludwig S; Scherl C; Rotter N
    Laryngorhinootologie; 2024 May; 103(5):371-382. PubMed ID: 38697084
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    Zhou Y; Wang W; Tang J; Hu K; Zhang F
    BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and Quantification of Radiotherapy-related Protein Expression in cancer Tissues Using the Qupath Software and Prediction of treatment Response.
    Hasegawa T; Someya M; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Okuda R; Kaguchi J; Ohguro A; Kamiyama R; Ashina A; Toshima Y; Hirohashi Y; Torigoe T; Sakata KI
    In Vivo; 2024; 38(3):1470-1476. PubMed ID: 38688633
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Radiotherapy for patients with esophageal cancer aged 80 years or older: A 16-year experience.
    Zhai T; Huang R; Zhan Y; Xu L; Yu Y; Guo L; Chen J; Su C; Chen C
    J Cancer Res Ther; 2024 Apr; 20(2):678-683. PubMed ID: 38687940
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development.
    Chen W; Xie X; Liu C; Liao J; Wei Y; Wu R; Hong J
    Cell Signal; 2024 Jul; 119():111192. PubMed ID: 38685522
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
    Arrossi S; Binder F; Ituarte C; Martiarena N; Campanera A; Bárcena M; Paolino M
    Medicina (B Aires); 2024; 84(2):236-248. PubMed ID: 38683508
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
    He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A Comparative Study of Clinical Outcomes in Locally Advanced cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
    Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Synergistic effect of human uterine cervical mesenchymal stem cell secretome and paclitaxel on triple negative breast cancer.
    Eiro N; Fraile M; Escudero-Cernuda S; Sendon-Lago J; Gonzalez LO; Fernandez-Sánchez ML; Vizoso FJ
    Stem Cell Res Ther; 2024 Apr; 15(1):121. PubMed ID: 38664697
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
    Hosseini MS; Shafizadeh F; Bahremani MH; Farzaneh F; Ashrafganjoei T; Arab M; Talayeh M; Jafari F; Abdshah A
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2057. PubMed ID: 38662366
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
    Lee LJ; Han CJ; Saligan L; Wallen GR
    Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Huang K; Huang X; Zeng C; Wang S; Zhan Y; Cai Q; Peng G; Yang Z; Zhou L; Chen J; Chen C
    Cancer Imaging; 2024 Apr; 24(1):54. PubMed ID: 38654284
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [
    Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
    BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 541.